Postpartum Family Planning Program in Rwanda
Launched by EMORY UNIVERSITY · Sep 23, 2021
Trial Information
Current as of July 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial in Rwanda is focused on improving postpartum family planning (PPFP), which helps women and families make informed choices about their reproductive health after giving birth. The goal is to find ways to provide better access to family planning services, which can help reduce unintended pregnancies and improve the health of mothers and newborns. The researchers will test a program that has already shown promise in smaller studies, and they want to see if it can be effectively used on a larger scale.
To participate in this trial, individuals must be involved in providing or promoting family planning services at selected healthcare facilities. This includes healthcare providers, nurses, community health workers, and postpartum women who are choosing a family planning method. Participants can expect to engage with a supportive program that aims to make family planning more accessible and tailored to their needs. Importantly, this study does not include individuals who are currently in prison. Overall, this trial represents an exciting opportunity to improve family planning support for new mothers in Rwanda.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eligible PPFP promoters will be government facility providers working in ANC,L\&D, IV and/or postpartum services at one of the study facilities.
- • Eligible PPFP providers will be government facility providers working in L\&D, and/or family planning services at one of the study facilities.
- • Eligible Happy Client promotors will be postpartum women who received promotions and selected a PPFP method.
- • Eligible nurse/midwife and CHW promotors will be women working as nurses or CHWs at one of the intervention facilities.
- • All women eligible for PPFP services in this study will be at any stage of pregnancy or up to 14 weeks postpartum, and receiving antenatal care (ANC), L\&D, IV, or postpartum services at one of the intervention or pilot facilities
- Exclusion Criteria:
- • Prisoners
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kigali, , Rwanda
Kigali, Kigali Province, Rwanda
Patients applied
Trial Officials
Kristin Wall, PhD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials